Your Article Summary
See Latest ArticlesAt-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists
Brain, 07/01/09
Abler B et al. - The results support the notion of a general medication effect in patients under dopamine receptor agonists in terms of a sensitization towards impulse control disorders.
Related Articles
Dopamine agonist-induced antecollis in Parkinsons disease
Movement Disorders, 11/18/09
Relevance Score: 71%
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
Cochrane Reviews, 10/09/09
Relevance Score: 70%
Prolactin and Autoimmunity
Clinical Reviews in Allergy and Immunology, 11/18/09
Relevance Score: 64%
The pragmatic use of apomorphine at the end of life
Palliative Medicine, 10/30/09
Relevance Score: 64%
Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole
Current Medical Research and Opinion, 10/26/09
Relevance Score: 64%
Today in Movement Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Assessment of depression in Parkinson's disease: the contribution of somatic symptoms to the clinimetric performance of the Hamilton and Montgomery-Asberg rating scales
Journal of Psychosomatic Research, 12/14/09
Incidence of Parkinson's Disease in Bulgaria
Neuroepidemiology , 12/14/09
Current strategies in the treatment of Parkinson’s disease and a personalized approach to management
Expert Review of Neurotherapeutics, 12/14/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
Acta Neurologica Scandinavica, 12/14/09
Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [11C] (R)-PK11195 PET (MEMSA-trial)
Movement Disorders, 12/14/09
Vitamin E Use Is Associated with Improved Survival in an Alzheimer’s Disease Cohort
Dementia and Geriatric Cognitive Disorders, 12/14/09